Celldex Therapeutics
CLDX
CLDX
95 hedge funds and large institutions have $23.2M invested in Celldex Therapeutics in 2018 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 21 increasing their positions, 32 reducing their positions, and 16 closing their positions.
Holders
95
Holders Change
-7
Holders Change %
-6.86%
% of All Funds
2.18%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
9
Increased
21
Reduced
32
Closed
16
Calls
$11K
Puts
$13K
Net Calls
-$2K
Net Calls Change
+$47K
Top Buyers
1 |
1
Renaissance Technologies
New York
|
$2.41M |
2 |
GCP
2
GSA Capital Partners
London,
United Kingdom
|
$573K |
3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$2.73M |
4 |
4
Two Sigma Investments
New York
|
$774K |
5 |
5
Two Sigma Advisers
New York
|
$288K |